CNVT (CNVT) Stock Price & Analysis
CNVT (CNVT) rose 0.00% to USD 0 as of June 10, 2026 at 14:21 UTC, according to Nexqual real-time market data.
CNVT last closed at USD 0; the session ranged USD 0.02–0.02 on volume of 19 shares. Market capitalization is $4,088, with a 52-week range of USD 0–0.02 (PNK). Source: Nexqual, June 10, 2026 at 14:21 UTC.
Key Statistics (as of June 10, 2026 at 14:21 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.02 |
| Volume | 19 shares |
| Market Cap | $4,088 |
| Exchange | PNK |
Technical Analysis (CNVT)
Nexqual's technical model rates CNVT "STRONG SELL" based on 0 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 14:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 90.12 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (CNVT)
Wall Street analysts rate CNVT "None", per Nexqual as of June 10, 2026 at 14:21 UTC.
| Consensus Rating | None |
|---|
Earnings (CNVT)
Source: Nexqual, June 10, 2026 at 14:21 UTC.
Financials & Fundamentals (CNVT)
| Total Revenue | $957,427 |
|---|---|
| Revenue Growth (YoY) | -51.30% |
| Gross Margin | +40.91% |
| Operating Margin | -305.03% |
| Profit Margin | +0.00% |
| Current Ratio | 0.1 |
| Total Cash | $114,961 |
| Total Debt | $103,127 |
| Free Cash Flow | $-14,425 |
Source: Nexqual, June 10, 2026 at 14:21 UTC.
Financial Health Score (CNVT)
Nexqual rates CNVT's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 14:21 UTC.
| Growth | Critical — Revenue -51% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $115K cash, no debt |
| Cash Flow | Weak — FCF negative: -$14K, burning cash |
| Efficiency | Mixed — No data |
Ownership (CNVT)
| Shares Outstanding | 40.88M |
|---|
Source: Nexqual, June 10, 2026 at 14:21 UTC.
Leadership (CNVT)
CNVT is led by Jeffrey I. Dreben (age 80), Chairman of the Board, Chief Executive Officer and President, per Nexqual as of June 10, 2026 at 14:21 UTC.
| Chairman of the Board, Chief Executive Officer and President | Jeffrey I. Dreben (age 80) |
|---|---|
| Co-Founder, Chief Operating Officer, Chief Technology Officer, Secretary, Treasurer and Director | Robert B. Nally (age 77) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▲ 0% |
| WOWI | Metro One Telecommunications, I | USD 0 | ▲ 0% |
| BBUZ | Bebuzee Inc. | USD 0.02 | ▲ 10.56% |
| CCWF | Church & Crawford, Inc. | USD 0 | ▲ 0% |
| TBPMQ | TETRA BIO PHARMA INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 14:21 UTC. This page is informational and not investment advice.